Renaud Lavend’homme

1.1k total citations
32 papers, 852 citations indexed

About

Renaud Lavend’homme is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Renaud Lavend’homme has authored 32 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 7 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Renaud Lavend’homme's work include Hemophilia Treatment and Research (26 papers), Platelet Disorders and Treatments (20 papers) and Blood Coagulation and Thrombosis Mechanisms (15 papers). Renaud Lavend’homme is often cited by papers focused on Hemophilia Treatment and Research (26 papers), Platelet Disorders and Treatments (20 papers) and Blood Coagulation and Thrombosis Mechanisms (15 papers). Renaud Lavend’homme collaborates with scholars based in Belgium, France and South Africa. Renaud Lavend’homme's co-authors include Marc Jacquemin, Kathelijne Peerlinck, Jean‐Marie Saint‐Remy, Jos Vermylen, Roseline d’Oiron, Nawal Jazouli, Étienne Sokal, Kris Covens, Jean Guy Gilles and Marc Hoylaerts and has published in prestigious journals such as Blood, Scientific Reports and Thorax.

In The Last Decade

Renaud Lavend’homme

30 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renaud Lavend’homme Belgium	14	648	221	134	134	80	32	852
D Samson United Kingdom	14	549 0.8×	213 1.0×	108 0.8×	40 0.3×	196 2.5×	23	684
Bernard A. Ruether Canada	14	364 0.6×	130 0.6×	73 0.5×	131 1.0×	135 1.7×	21	519
K. H. Th'ng United Kingdom	14	458 0.7×	88 0.4×	270 2.0×	34 0.3×	97 1.2×	19	622
Anastasia Athanasiadou Greece	16	203 0.3×	141 0.6×	314 2.3×	59 0.4×	103 1.3×	45	604
SN Rabinowe United States	10	425 0.7×	106 0.5×	333 2.5×	66 0.5×	230 2.9×	16	804
Isabella Garagiola Italy	11	697 1.1×	181 0.8×	196 1.5×	20 0.1×	37 0.5×	13	871
PI Warkentin United States	15	589 0.9×	53 0.2×	139 1.0×	26 0.2×	201 2.5×	28	718
Shebli Atrash United States	13	521 0.8×	403 1.8×	114 0.9×	73 0.5×	454 5.7×	119	752
Lon Smith United States	5	604 0.9×	427 1.9×	106 0.8×	44 0.3×	399 5.0×	6	769
T Radaszkiewicz Austria	14	191 0.3×	88 0.4×	114 0.9×	96 0.7×	117 1.5×	27	643

Countries citing papers authored by Renaud Lavend’homme

Since Specialization

Citations

This map shows the geographic impact of Renaud Lavend’homme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Lavend’homme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Lavend’homme more than expected).

Fields of papers citing papers by Renaud Lavend’homme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renaud Lavend’homme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Lavend’homme. The network helps show where Renaud Lavend’homme may publish in the future.

Co-authorship network of co-authors of Renaud Lavend’homme

This figure shows the co-authorship network connecting the top 25 collaborators of Renaud Lavend’homme. A scholar is included among the top collaborators of Renaud Lavend’homme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renaud Lavend’homme. Renaud Lavend’homme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lavend’homme, Renaud, Chantal Thys, Sam Noppen, et al.. (2025). Functional assessment of genetic variants in thrombomodulin detected in patients with bleeding and thrombosis. Blood. 145(17). 1929–1942. 3 indexed citations

Verhulst, Stefaan, Willeke de Haan, Stefan Vinckier, et al.. (2025). Loss of endothelial ZEB2 in mice attenuates steatosis early during metabolic dysfunction-associated steatotic liver disease. Scientific Reports. 15(1). 23434–23434.

Rokni‐Zadeh, Hassan, et al.. (2022). Pro‐haemostatic effect of DDAVP is partially derived through non‐classical (CD14^dim/CD16⁺⁺) monocytes residing the spleen. Journal of Cellular and Molecular Medicine. 27(1). 30–35. 1 indexed citations

Covens, Kris, Renaud Lavend’homme, Nawal Jazouli, et al.. (2013). Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII. Journal of Thrombosis and Haemostasis. 12(1). 36–42. 139 indexed citations

Rinaldi, Manuela, An Lehouck, Renaud Lavend’homme, et al.. (2012). Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease. Thorax. 67(8). 694–700. 35 indexed citations

Pautard, Brigitte, Roseline d’Oiron, Renaud Lavend’homme, et al.. (2011). Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII‐specific T cells. Journal of Thrombosis and Haemostasis. 9(6). 1163–1170. 17 indexed citations

Lavend’homme, Renaud, et al.. (2010). Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool. Blood. 115(23). 4902–4909. 58 indexed citations

Jacquemin, Marc, J M Stassen, Peter Verhamme, et al.. (2008). A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons. Journal of Thrombosis and Haemostasis. 7(3). 429–437. 17 indexed citations

Jacquemin, Marc, Renaud Lavend’homme, Jean-Marie Saint-Remy, & Kathelijne Peerlinck. (2007). Activation of human endothelial cells induces the release of a FVIII storage pool. Journal of Thrombosis and Haemostasis. 5. 1 indexed citations

10.

Jacquemin, Marc, Arne Neyrinck, Maria Iris Hermanns, et al.. (2006). FVIII production by human lung microvascular endothelial cells. Blood. 108(2). 515–517. 75 indexed citations

11.

Jacquemin, Marc, Catherine M. Radcliffe, Renaud Lavend’homme, et al.. (2006). Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody. Journal of Thrombosis and Haemostasis. 4(5). 1047–1055. 37 indexed citations

12.

Jacquemin, Marc, Renaud Lavend’homme, Abdellah Benhida, et al.. (2004). Rupture of T Cell Tolerance to Self Factor VIII in Mild/Moderate Hemophilia A.. Blood. 104(11). 3076–3076. 1 indexed citations

13.

d’Oiron, Roseline, J. M. Lavergne, J Peynet, et al.. (2003). Response to DDAVP in mild/moderate haemophilia A patients according to the underlying Factor VIII genotype. Journal of Thrombosis and Haemostasis. 1. 4 indexed citations

14.

Jacquemin, Marc, et al.. (2003). Molecular mechanisms of mild and moderate hemophilia A. Journal of Thrombosis and Haemostasis. 1(3). 456–463. 36 indexed citations

15.

Jacquemin, Marc, Valérie Vantomme, Cécile Buhot, et al.. (2003). CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A. Blood. 101(4). 1351–1358. 91 indexed citations

16.

Jacquemin, Marc, Cécile Buhot, Renaud Lavend’homme, et al.. (2002). A single mutation Arg2150His regulates T cell specificity for the FVIII C1 domain: a molecular mechanism responsible for the higher incidence of inhibitors in mild/moderate hemophilia A patients with mutations in the C1 domain. 1 indexed citations

17.

Jacquemin, Marc, Kathleen P. Pratt, Carol A. Spiegel, et al.. (2001). Deletion of residue Ala2201 in the Factor VIII C2 domain results in mild haemophilia A and destroys a major antigenic determinant recognized by Factor VIII inhibitor antibodies. 1 indexed citations

18.

Jacquemin, Marc, Renaud Lavend’homme, Abdellah Benhida, et al.. (2000). A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor. Blood. 96(3). 958–965. 7 indexed citations

19.

Peerlinck, Kathelijne, Jozef Arnout, Marc Jacquemin, et al.. (1997). A patient with mild hemophilia A and a high titer antifactor VIII antibody against exogenous factor VIII only: clinical features, surgical management, and partial characterization of the inhibitor. Blood. 90. 3 indexed citations

20.

Gilles, Jean Guy, Renaud Lavend’homme, Marc Jacquemin, et al.. (1997). Anti-Factor VIII inhibitory antibodies belonging to the IgA1 isotype in a mild hemophilia A patient. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact